Adenosine Monophosphate Activated Kinase (AMPK) the Breakthrough Target for Metabolic Syndrome
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2014, Vol 2, Issue 3
Abstract
Abstract: Metabolic syndrome is the challenging condition in current scenario in developing countries. To overcome it, the best target identification is the most challenging task. The enzyme Adenosine Monophosphate Activated Protein Kinase (AMPK) could be one of the targets to battle against such intricate conditions. The Adenosine Monophosphate Activated Protein Kinase (AMPK), a heterotrimeric serine/threonine protein kinase. Activated AMPK switches cells from an anabolic to a catabolic state, shutting down the ATP-consuming synthetic pathways and restoring energy balance, regulates key metabolic enzymes to reduce the activity of ATP-utilizing biosynthetic pathways and increase the activity of ATP-generating pathway. The fuel-sensing enzyme 5'-AMP-activated protein kinase (AMPK) has a major role in the regulation of cellular lipid and protein metabolism in response to stimuli such as exercise, changes in fuel availability and the adipocyte-derived hormones leptin and adiponectin. Abnormalities in cellular lipid metabolism are involved in the pathogenesis of the metabolic syndrome, possibly because of dysregulation of AMPK and Malonyl-CoA.It is now recognized that pharmacological activation of AMPK improves blood glucose homeostasis, lipid profile and blood pressure in insulin-resistant conditions. Indeed, AMPK activation mimics the beneficial effects of physical activity or those of calorie restriction by acting on multiple cellular targets. In addition, AMPK is one of the probable targets of major antidiabetic drugs including, the biguanides (metformin) and thiazolidinedione, as well as of insulin sensitizing adipokines (e.g., adiponectin). Taken together, such findings highlight the logic underlying the concept of targeting the AMPK pathway for the treatment of metabolic syndrome. Keywords: Metabolic syndrome, AMPK, ACC-2, HMGCo-A Reductase, CPT.
Authors and Affiliations
Abhishek B. Jha
Keywords
Related Articles
- EP ID EP374308
- DOI -
- Views 72
- Downloads 0
Prevalence of H. pylori Infection and Atrophic Gastritis among dyspeptic subjects in Cameroon using a Panel of Serum Biomarkers (PGI,PGII, G-17, HpIgG)
Abstract: H. pylori infection induces chronic active gastritis that develops with time in a proportion of infected people to atrophic gastritis (AG) and acid free or hypochlorhydric stomach.Objective: Use of a non-invasi...
Correlation of Dyslipideamia among Hypothyroidism and Type II Diabetes Mellitus
Hypothyroidism and diabetes mellitus (DM) are the two most common endocrine disorders, which are on simultaneous rise. Dyslipidemia is common metabolic abnormalities in hypothyroidism and diabetes mellitus with marked in...
Missed-Opportunities of Health Care Services in Persons Accompanying the Patients
Utilization of health services depends on its social legitimization in the household – in other words, its affirmation and endorsement of health seeking behavior. The Objectives were to study the reasons of missed opport...
Assessment of serum Prostate specific antigen (PSA) level among Sudanese women with polycystic ovarian syndrome In Khartoum state
Abstract: PCOS is one of the commonest endocrine disorders in women of reproductive age group, cause of androgen excess in women. Prostatic specific antigen (PSA) is the most specific prostatic tumor marker in...
Stress and it’s Coping Strategies in Medical Students
Medical education consists of imparting knowledge, health and development, necessary skills and applications of available sources to overcome stress. Stress in medical education is common and process-oriented. It often e...